TipRanks
IGC Pharma (DE:IGS1)
FRANKFURT:IGS1
Germany Market
IGS1
IGC Pharma
RESEARCH TOOLSreports

IGC Pharma (IGS1) Income Statement

6 Followers

IGC Pharma Income Statement

Last quarter (Q1 2027), IGC Pharma's total revenue was $265.00K, a decrease of -19.21% from the same quarter last year. In Q1, IGC Pharma's net income was $-2.94M. See IGC Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Jun 23Mar 22
Total Revenue
$ 1.19M$ 1.27M$ 1.34M$ 911.00K$ 397.00K
Gross Profit
$ 352.00K$ 619.00K$ 733.00K$ -158.00K$ 194.00K
Operating Expenses
$ 10.55M$ 8.06M$ 10.53M$ 11.41M$ 15.62M
Depreciation and Amortization
$ 324.00K$ 464.00K$ 637.00K$ 657.00K$ 651.00K
EBITDA
$ -6.22M$ -6.66M$ -12.36M$ -10.85M$ -14.37M
Operating Income
$ -10.20M$ -7.45M$ -9.80M$ -11.57M$ -15.43M
Other Income/Expenses
$ 3.65M$ 325.00K$ -3.20M$ 65.00K$ 412.00K
Pretax Income
$ -6.55M$ -7.12M$ -13.00M$ -11.51M$ -15.02M
Net Income
$ -6.55M$ -7.12M$ -13.00M$ -11.51M$ -15.02M
Per Share Metrics
Basic EPS
$ -0.07$ -0.09$ -0.22$ -0.22$ -0.30
Diluted EPS
$ -0.07$ -0.09$ -0.22$ -0.22$ -0.30
Weighted Average Shares Outstanding
 95.04M 76.52M 58.84M 52.58M 49.99M
Weighted Average Shares Outstanding (Diluted)
 95.04M 76.52M 58.84M 52.58M 49.99M
Currency in USD

IGC Pharma Earnings and Revenue History